Robert P Nelson Jr
Overview
Explore the profile of Robert P Nelson Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
849
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Agrawal V, Ranganath P, Ervin K, Schmidt C, Cox E, Nelson Jr R, et al.
Bone Marrow Transplant
. 2020 Jul;
56(1):121-128.
PMID: 32623447
Sinusoidal obstruction syndrome (SOS) is a serious complication of hematopoietic stem cell transplantation (HSCT). Sirolimus plus tacrolimus is an accepted regimen for graft-versus-host disease (GVHD) prophylaxis, with both agents implicated...
2.
Sarker J, Pearce S, Nelson Jr R, Kinzer-Ursem T, Umulis D, Rundell A
BMC Syst Biol
. 2017 Aug;
11(1):78.
PMID: 28841879
Background: Acute myelogenous leukemia (AML) progresses uniquely in each patient. However, patients are typically treated with the same types of chemotherapy, despite biological differences that lead to differential responses to...
3.
Bonilla F, Khan D, Ballas Z, Chinen J, Frank M, Hsu J, et al.
J Allergy Clin Immunol
. 2015 Sep;
136(5):1186-205.e1-78.
PMID: 26371839
The American Academy of Allergy, Asthma & Immunology (AAAAI) and the American College of Allergy, Asthma & Immunology (ACAAI) have jointly accepted responsibility for establishing the "Practice parameter for the...
4.
Lim L, Moorthy R, Najm S, Nelson Jr R, Wolf K, Lahm T
Retin Cases Brief Rep
. 2014 Nov;
6(2):204-5.
PMID: 25390964
Purpose: To report a novel posterior segment manifestation of Whipple disease. Method: Single observational case study. Results: The white crystalline deposit in the retina, choroiditis, and vitritis resolved with treatment...
5.
Khawaja M, Perkins S, Schwartz J, Robertson M, Kiel P, Sayar H, et al.
Am J Hematol
. 2014 Oct;
90(2):97-9.
PMID: 25345651
We compared survival outcomes following myeloablative allotransplant (MAT) or cyclophosphamide/fludarabine (Cy/Flu) nonmyeloablative allotransplant (NMAT) for 165 patients with acute myelogenous leukemia (AML) in remission or without frank relapse. Patients who...
6.
Nelson Jr R, Khawaja M, Perkins S, Elmore L, Mumaw C, Orschell C, et al.
Biol Blood Marrow Transplant
. 2014 Jul;
20(11):1861-4.
PMID: 25017764
Five candidate plasma biomarkers (suppression of tumorogenesis 2 [ST2], regenerating islet-derived-3α [REG3α], elafin, tumor necrosis factor receptor 1 [TNFR1], and soluble IL-2 receptor-alpha [sIL2Rα]) were measured at specific time points...
7.
Leathers C, Azar M, Badve S, Roth T, Loehrer P, Nelson Jr R
J Allergy Clin Immunol Pract
. 2014 Feb;
1(4):413-5.
PMID: 24565551
No abstract available.
8.
Jolles S, Borte M, Nelson Jr R, Rojavin M, Bexon M, Lawo J, et al.
Clin Immunol
. 2014 Jan;
150(2):161-9.
PMID: 24412910
Hizentra(®) (20% subcutaneous immunoglobulin [SCIG]) was administered to subjects with primary immunodeficiency disease in two extension studies in the EU and US to assess long-term efficacy and tolerability. Subjects (aged...
9.
de la Morena M, Nelson Jr R
Clin Rev Allergy Immunol
. 2013 Jul;
46(2):131-44.
PMID: 23832379
Hematopoietic cell transplantation (HCT) is a curative therapeutic option for severe combined immunodeficiency (SCID), a group of diseases which otherwise carry life expectancies that are of limited duration and quality....
10.
Gokmen-Polar Y, Sanders K, Goswami C, Cano O, Zaheer N, Jain R, et al.
Lab Invest
. 2012 Aug;
92(11):1564-73.
PMID: 22926645
Thymomas are low-grade epithelial tumors of the anterior mediastinum. The complexity of the disease and the lack of in vitro and in vivo models hamper the development of better therapeutics....